NCT02617420
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,736 public trials
631 recruiting studies
Hypersensitivity, Immediate trial results
NCT00370591
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Manchester, Lancashire, United Kingdom
NCT00107757
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Costa Mesa, California, United States
- GSK Investigational Site Cudahy, California, United States
NCT00109486
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +11 more
- Locations
-
- GSK Investigational Site Randers, Denmark
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
- GSK Investigational Site Pleven, Bulgaria
- GSK Investigational Site Sofia, Bulgaria
- GSK Investigational Site Sofia, Bulgaria
NCT00169546
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Wellington, New Zealand
- GSK Investigational Site Manchester, Lancashire, United Kingdom
NCT00354874
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Wiesbaden, Hesse, Germany
- GSK Investigational Site Großhansdorf, Schleswig-Holstein, Germany
- GSK Investigational Site Gothenburg, Sweden
NCT02620956
- Conditions
- Asthma, Body Weight, Bronchial Diseases, +15 more
- Locations
-
- Hospital the Federal University of Pernambuco Recife, Pernambuco, Brazil
Completed
Advair Pediatric Once-Daily
NCT00920959
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Ozark, Alabama, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
Completed
A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults
NCT00116818
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- GSK Investigational Site San Antonio, Texas, United States
- GSK Investigational Site Mississauga, Ontario, Canada